First Republic Investment Management, Inc. Mi Nk Therapeutics, Inc. Transaction History

First Republic Investment Management, Inc.

  • $34.7 Billion
  • Q3 2023

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 11, 2023
SELL
$1.9 - $2.48 $38,190 - $49,848
-20,100 Reduced 38.29%
32,400 $61,000
Q4 2022

Feb 13, 2023
SELL
$1.89 - $3.16 $54,810 - $91,640
-29,000 Reduced 35.58%
52,500 $137,000
Q3 2022

Nov 03, 2022
BUY
$1.19 - $3.4 $96,985 - $277,100
81,500 New
81,500 $172,000

Others Institutions Holding INKT

# of Institutions
29
Shares Held
848K
Call Options Held
0
Put Options Held
0
View Full List

About MiNK Therapeutics, Inc.

INKT Quotes by TradingView
  • Ticker INKT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 33,775,100
  • Market Cap $17.6M
  • Description
  • MiNK Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in the discovery, development, and commercialization of allogeneic, off-the-shelf, invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases. Its product candidate is AGENT-797, an off-the-shelf, allogeneic for iNKT cell therapy...
More about INKT
Track This Portfolio

Track First Republic Investment Management, Inc. Portfolio

Follow First Republic Investment Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Republic Investment Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on First Republic Investment Management, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email